Albireo Pharma Inc.
13F holders, Q2 2024 (June 30)3holders
0new positions
0sold out
$0.00avg. 13F price*
At the end of Q2 2024, 3 institutions reported holding Albireo Pharma Inc. in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holders were MAI Capital Management ($0), Tucker Asset Management LLC ($0) and GAMMA Investing LLC ($0).
- Company
- Albireo Pharma Inc.
- CUSIP
- 013CVR022
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 477 shares sold, net −477 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| MAI Capital Management | 0.00% | Reduce -0.3% | 150,183 | $0 |
| Tucker Asset Management LLC | 0.00% | No change | 150 | $0 |
| GAMMA Investing LLC | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is ALBIREO PHARMA INC's weight in each manager's 13F, not the share of Albireo Pharma Inc. the manager owns.